semaglutide cardiovascular outcomes study news and in Obesity without Diabetes: The SELECT Trial semaglutide cardiovascular outcomes news today

2 The first retrospective study, which was based out of Medical University of South Carolina, assessed adults 50 years old and older without diabetes who were prescribed a GLP-1 agent or other weight loss medphentermine, orlistat, setmelanotide, phentermine-topiramate or bupropion-naltrexone

Zheng L, Zhang S

Appetite fluctuation during the transition period deserves special attention

In this study, groups with higher GGT levels showed dose-dependent elevations in all-cause mortality and cardiovascular disease when adjusted for age, sex, body mass index (BMI), blood pressure, alcohol consumption, and smoking

Glucagon-like Peptide Receptor-1 (GLP-1R) : When this receptor is activated, it slows down how fast the stomach empties